In-patient versus out-patient withdrawal programmes for medication overuse headache: A 2-year randomized trial

Cephalalgia

Volumn 31, Issue 11, 2011, Pages 1189-1198

  Creac'H C ^a,b   Frappe, P ^c   Cancade, M ^a   Laurent, B ^a,b   Peyron, R ^a,b   Demarquay, G ^d   Navez, M ^a  

^a North University Hospital   (France)

^b CNRL 1028 Saint Etienne   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d Croix Rousse Hospital   (France)

Author keywords

Chronic daily headache; dependency; in patient withdrawal; medication overuse headache; migraine; out patient withdrawal

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUNARIZINE; INDORAMIN; METOCLOPRAMIDE; NARCOTIC ANALGESIC AGENT; NEFOPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OXETORONE; PIZOTIFEN; SEDATIVE AGENT; TOPIRAMATE; TRIPTAN DERIVATIVE; VENLAFAXINE; VERAPAMIL;

ADULT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; CRYOTHERAPY; DISTRESS SYNDROME; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EMERGENCY TREATMENT; EPISODIC HEADACHE; FEMALE; HEALTH PROGRAM; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIGRAINE; NAUSEA; OUTCOME ASSESSMENT; OUTPATIENT; OUTPATIENT CARE; PATIENT COMPLIANCE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; TENSION HEADACHE; THERAPY EFFECT; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADULT; AGED; ANALGESICS; FEMALE; HEADACHE DISORDERS; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; REHABILITATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 80051491732     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411412088     Document Type: Article

References (55)

1. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
2. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999 ; 39: 190-196 (Pubitemid 29190083)
3. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 ; 106: 81-89 (Pubitemid 37329617)
4. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology. 2003 ; 61: 160-164 (Pubitemid 36875294)
5. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse. Epidemiology and impact on quality of life. Neurology. 2004 ; 62: 1338-1342 (Pubitemid 38526046)
6. Wang SJ, Fuh JL. Medication overuse headache in Taiwan. Cephalalgia. 2008 ; 28: 1240-1242
7. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
8. Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology. 2006 ; 66: 198-201 (Pubitemid 43970153)
9. Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents: an 8-year follow-up study. Neurology. 2009 ; 73: 416-422
10. Diener H, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet. 2004 ; 3: 475-483 (Pubitemid 38903098)
11. Katsarava Z, Diener HC. Medication overuse headache in Germany. Cephalalgia. 2008 ; 28: 1221-1222
12. Dodick DW, Silberstein SD. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia. 2008 ; 28: 1207-1217
13. Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother. 1999 ; 33: 61-72 (Pubitemid 29056559)
14. Taimi C, Navez M, Perrin AM, Laurent B. [Headaches caused by abuse of symptomatic anti-migraine and analgesic treatment.] Rev Neurol (Paris) 2001; 157: 1221-1234.
15. Cupini LM, Sarchielli P, Calabresi P. Medication overuse headache: neurobiological, behavioural and therapeutic aspects. Pain. 2010 ; 150: 222-224
16. ANAES. Céphalées chroniques quotidiennes: diagnostic, rôle de l'abus médicamenteux, prise en charge. http://www.has- sante.fr/portail/upload/docs/application/pdf/CCQ-guidelines.pdf.
17. Pascual J, Mateos V, Gracia M, Lainez JM. Medication overuse headache in Spain. Cephalalgia. 2008 ; 28: 1234-1236
18. Kanki R, Nagaseki Y, Sakai F. Medication-overuse headache in Japan. Cephalalgia. 2008 ; 28: 1227-1228
19. Ravishankar K. Medication overuse headache in India. Cephalalgia. 2008 ; 28: 1223-1226
20. Diagnosis and management of headache in adults. A national clinical guideline. Edinburgh: SIGN ; 2008: 35-37.
21. Pini LA, Bigarelli M, Vitale G, Sternieri E. Headaches associated with chronic use of analgesics: a therapeutic approach. Headache. 1996 ; 36: 433-439 (Pubitemid 26260749)
22. Suhr BE, Evers S, Bauer B, Gralow I, Grotmeyer KH, Husstedt IW. Drug-induced headache: long term results of stationary versus ambulatory withdrawal therapy. Cephalalgia. 1999 ; 19: 44-49 (Pubitemid 29136851)
23. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006 ; 26: 1097-1105 (Pubitemid 44199401)
24. Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008 ; 28: 1196-1200
25. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia. 2009 ; 29: 855-863
26. Créac'h C, Radat F, Mick G, Guegan-Massardier E, Giraud P, Guy N, et al. One or several types of triptan overuse headaches?. Headache. 2009 ; 49: 519-528
27. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 ; 67: 361-370 (Pubitemid 13098606)
28. Lépine JP L'évaluation clinique standardisée en psychiatrie. Guelfi JD, ed. Paris: Editions médicales Pierre fabre ; 1996: 367-374.
29. ANAES. Prise en charge diagnostique et thérapeutique de la migraine chez l'adulte et chez l'enfant: aspects cliniques et économiques. http://www.has-sante.fr/portail/upload/docs/application/pdf/ migraine-recos.pdf.
30. Taimi C, Navez M, Perrin AM, Laurent B. Céphalées par abus des traitements symptomatiques antalgiques et anti-migraineux: analyse des données recueillies, évaluation du vécu et de l'efficacité du sevrage effectué par 43 patients du centre anti-douleur de Saint-Etienne. Doul et Analg. 2002 ; 3: 115-124 (Pubitemid 35167855)
31. Diener HC, Gerber WD, Geiselhart S, Dichgans J Drug-induced headache. Diener HC Wilkinson M, ed. Berlin: Springer ; 1988: 133-142.
32. Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, et al. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada. Cephalalgia. 2006 ; 26: 578-588
33. Meskunas CA, Tepper SJ, Rapoport AM, Sheftell FD, Bigal ME. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006 ; 46: 766-772
34. Katsarava Z, Fritsche G, Muessig M, Diener H, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001 ; 57: 1694-1698 (Pubitemid 33055491)
35. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002 ; 59: 1011-1014
36. Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia. 2000 ; 20: 658-662 (Pubitemid 32269463)
37. Krymchantowski AV, Moreira PF. Outpatient detoxification in chronic migraine: comparison of strategies. Cephalalgia. 2003 ; 23: 982-993 (Pubitemid 37521952)
38. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007 ; 27: 1219-1225 (Pubitemid 47631900)
39. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006 ; 26: 1192-1198 (Pubitemid 44359339)
40. Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence?. Pain. 2005 ; 119: 49-55
41. Ferrari A, Cicero AF, Bertolini A, Leone S, Pasciullo G, Sternieri E. Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia. 2006 ; 26: 187-193
42. Radat F, Créac'h C, Guegan-Massardier E, Mick G, Guy N, Fabre N, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 ; 48: 1026-1036 (Pubitemid 351952107)
43. Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache?. Headache. 2010 ; 50: 1597-1611
44. Sances G, Ghiotto N, Galli F, Guaschino E, Rezzani C, Guidetti V, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia 2009. E-pub ahead of print, DOI: 10.1111/j.1468-2982. 2009.01934.x.
45. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol. 1989 ; 236: 9-14 (Pubitemid 19113116)
46. Pini LA, Cicero A, Sandrini M. Long-term follow -up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001 ; 21: 878-883 (Pubitemid 34621510)
47. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. Eur J Neurol. 2009 ; 16: 705-712
48. Schnider P, Aull S, Baumgartner C, Marterer A, Wober C, Zeiler K, et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia. 1996 ; 16: 481-485 (Pubitemid 26373785)
49. Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener HC, Limmroth V. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005 ; 25: 12-15 (Pubitemid 40143787)
50. Hagen K, Albretsen C, Vilming ST, Salvesen R, Gronning M, Helde G, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009 ; 29: 221-232
51. Lafittau M, Radat F, Irachabal S, Créac'h C. Headache and transformed migraine with medication overuse: what differences between disability, emotional distress and coping?. Encephale. 2006 ; 32: 231-237
52. Sancisi E, Rausa M, Zanigni S, Cevoli S, Pala AN, Nicodemo M, et al. Self-help group and medication overuse headache: preliminary data. Neurol Sci. 2009 ; 30: 459-463
53. Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027
54. Rousselon V, Créac'h C, Sarrazin M, Cancade M, Flori S, Navez M. Céphalées par abus médicamenteux: enquête auprès de 54 médecins généralistes. Rev Prat Med Gen. 2005 ; 19: 1230-1234
55. Klapper JA. Denial of hospitalization by insurers for inpatient treatment of medication rebound headaches. Headache. 1994 ; 34: 601-602 (Pubitemid 24378715)